The company is developing an oxygen delivery system to treat hemorrhagic shock in situations with limited blood availability. This system aims to address blood shortages in both human and animal patients by providing an alternative method for oxygen delivery.
Funding
Funding not disclosed
Founders
Product
Problem
Both human and veterinary medicine face critical challenges in delivering oxygen during emergencies due to blood shortages, infection risks, and logistical limitations in blood supply chains. This vulnerability affects trauma patients and animals requiring critical care during surgeries or trauma when blood transfusions are not readily available or viable.
Solution
ReBlood Rx is developing a hemoglobin-based oxygen carrier (HBOC) derived from expired blood, designed to provide a universally compatible and efficient solution for oxygen delivery in diverse medical scenarios. The HBOC aims to address the limitations of traditional blood transfusions by offering a safe alternative that can be stored and transported at room temperature or frozen for stockpiling. By recycling expired blood and purifying its hemoglobin, ReBlood Rx intends to create a readily available oxygen-carrying solution that fills critical gaps in emergency care, surgical procedures, and remote healthcare settings for both human and animal patients. The HBOC is designed to alleviate cardiovascular issues previously observed with hemoglobin-based treatments.
Target Audience
The primary target audience includes medical professionals in emergency care, surgical units, and remote healthcare facilities, as well as veterinary professionals treating pets, livestock, and zoo animals.
Features
- Hemoglobin-based oxygen carrier (HBOC) derived from recycled, expired blood.
- Universally compatible oxygen delivery solution suitable for both human and animal use.
- Can be stored and transported at room temperature or frozen for stockpiling.
- Addresses blood shortages, infection risks, and supply chain limitations.
- Designed to alleviate previously observed cardiovascular issues associated with HBOCs.
- GMP facility under construction to ensure adherence to the highest manufacturing standards.